Literature DB >> 1424189

Cardiac conduction in patients with hypercalcaemia due to primary hyperparathyroidism.

M Rosenqvist1, J Nordenström, M Andersson, O K Edhag.   

Abstract

OBJECTIVE: To assess whether hypercalcaemia due to primary hyperparathyroidism is associated with significant cardiac arrhythmias. DESIGN AND PARTICIPANTS: The prevalence of cardiac arrhythmias and conduction disturbances was evaluated by 12-lead ECG and 24-hour long-term ECG during pre-surgical hypercalcaemia and after post-surgical normalization of serum calcium values in 20 patients with primary hyperparathyroidism.
RESULTS: After surgery, mean +/- SD calcium levels decreased from 2.85 +/- 0.1 to 2.40 +/- 0.1 mmol/l (P < 0.001). There was a significant increase in QT-intervals (0.36 +/- 0.05 vs 0.39 +/- 0.05) and QTc-intervals (0.38 +/- 0.04 vs 0.42 +/- 0.03) after surgery (P < 0.01). Long-term ECG showed no change in the minimal heart rate 47 +/- 8 vs 48 +/- 7 beats/min or in the longest RR interval 1.6 +/- 0.5 vs 1.6 +/- 0.5 s (P NS). There was no difference in the prevalence of supraventricular or ventricular arrhythmias. No episode of high-grade AV-block was observed before surgery. Circadian heart rate rhythm did not change between investigations.
CONCLUSIONS: It is concluded that moderate hypercalcaemia, in spite of causing a shortening of the repolarization phase (QT-interval), has no clinically significant effect on cardiac conduction.

Entities:  

Mesh:

Year:  1992        PMID: 1424189     DOI: 10.1111/j.1365-2265.1992.tb02279.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  12 in total

1.  Parathyroid hormone is related to QT interval independent of serum calcium in patients with coronary artery disease.

Authors:  Nicholas O Palmeri; Karina W Davidson; William Whang; Ian M Kronish; Donald Edmondson; Marcella D Walker
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-09-26       Impact factor: 1.468

2.  Dynamic assessment of the electrocardiographic QT interval during citrate infusion in healthy volunteers.

Authors:  T M Davis; B Singh; K E Choo; J Ibrahim; J L Spencer; A St John
Journal:  Br Heart J       Date:  1995-06

Review 3.  "Asymptomatic" and symptomatic primary hyperparathyroidism.

Authors:  J A Fischer
Journal:  Clin Investig       Date:  1993-07

4.  Atrioventricular nodal dysfunction secondary to hyperparathyroidism.

Authors:  Athanasios Vosnakidis; Konstantinos Polymeropoulos; Paul Zarogoulidis; Ioannis Zarifis
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

5.  Primary Hyperparathyroidism Is Associated With Shorter QTc Intervals, but Not Arrhythmia.

Authors:  Latoya A Stewart; Gabrielle K Steinl; Bernice L Huang; Catherine McManus; James A Lee; Jennifer H Kuo; Marcella D Walker
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 6.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 7.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 8.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

9.  Heart block and acute kidney injury due to hyperparathyroidism-induced hypercalcemic crisis.

Authors:  Taylor C Brown; James M Healy; Mary J McDonald; Joni H Hansson; Courtney E Quinn
Journal:  Yale J Biol Med       Date:  2014-12-12

10.  Fatal cardiovascular instability secondary to hypercalcaemia and intracellular calcium deposition complicating T-cell leukaemia-lymphoma.

Authors:  Stephen J Shepherd; Davina Wong; Ula Mahadeva; David Goldsmith; Manu Shankar-Hari; Marlies Ostermann
Journal:  JRSM Open       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.